153 related articles for article (PubMed ID: 33933018)
1. How to manage synchronous endometrial and ovarian cancer patients?
Shin W; Park SY; Kang S; Lim MC; Seo SS
BMC Cancer; 2021 May; 21(1):489. PubMed ID: 33933018
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic variables and survival comparison of patients with synchronous endometrial and ovarian cancers versus primary endometrial cancer with ovarian metastasis.
Oranratanaphan S; Manchana T; Sirisabya N
Asian Pac J Cancer Prev; 2008; 9(3):403-7. PubMed ID: 18990010
[TBL] [Abstract][Full Text] [Related]
3. [Clinicopathologic and survival analysis of synchronous primary endometrial and ovarian cancer].
Wang Y; Yu M; Yang JX; Cao DY; Zhang Y; Shen K; You Y
Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):816-822. PubMed ID: 30585019
[No Abstract] [Full Text] [Related]
4. [Synchronous primary cancers of the endometrium and ovary: review of 43 cases].
Ma SK; Zhang HT; Sun YC; Wu LY
Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):690-4. PubMed ID: 19173912
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors of synchronous endometrial and ovarian endometrioid carcinoma.
Yoneoka Y; Yoshida H; Ishikawa M; Shimizu H; Uehara T; Murakami T; Kato T
J Gynecol Oncol; 2019 Jan; 30(1):e7. PubMed ID: 30479091
[TBL] [Abstract][Full Text] [Related]
6. Characteristics and prognosis of coexisting adnexa malignancy with endometrial cancer: a single institution review of 51 cases.
Chen L; Zhao Q; Lv X
Arch Gynecol Obstet; 2011 May; 283(5):1133-7. PubMed ID: 20585952
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors in women with synchronous endometrial and ovarian cancers.
Song T; Seong SJ; Bae DS; Kim JH; Suh DH; Lee KH; Park SY; Lee TS
Int J Gynecol Cancer; 2014 Mar; 24(3):520-7. PubMed ID: 24552892
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic and survival analyses of synchronous primary endometrial and epithelial ovarian cancers.
Sozen H; Vatansever D; Iyibozkurt AC; Topuz S; Ozsurmeli M; Salihoglu Y; Guzelbey B; Berkman S
J Obstet Gynaecol Res; 2015 Nov; 41(11):1813-9. PubMed ID: 26369625
[TBL] [Abstract][Full Text] [Related]
9. Survival analysis of endometrial cancer patients with positive lymph nodes.
Brown AP; Gaffney DK; Dodson MK; Soisson AP; Belnap TW; Alleman K; Sause WT
Int J Gynecol Cancer; 2013 Jun; 23(5):861-8. PubMed ID: 23598890
[TBL] [Abstract][Full Text] [Related]
10. Synchronous primary ovarian and endometrial cancers: a population-based assessment of survival.
Williams MG; Bandera EV; Demissie K; RodrÃguez-RodrÃguez L
Obstet Gynecol; 2009 Apr; 113(4):783-789. PubMed ID: 19305320
[TBL] [Abstract][Full Text] [Related]
11. Synchronous primary endometrial and ovarian cancers: a multicenter review of 63 cases.
Solmaz U; Karatasli V; Mat E; Dereli L; Hasdemir PS; Ekin A; Gezer C; Sayhan S; Sanci M; Guvenal T
Tumori; 2016 Oct; 102(5):508-513. PubMed ID: 26166222
[TBL] [Abstract][Full Text] [Related]
12. Prognosis of women with stage I endometrioid endometrial cancer and synchronous stage I endometrioid ovarian cancer.
Matsuo K; Machida H; Frimer M; Marcus JZ; Pejovic T; Roman LD; Wright JD
Gynecol Oncol; 2017 Dec; 147(3):558-564. PubMed ID: 28986093
[TBL] [Abstract][Full Text] [Related]
13. Role of adjuvant therapy in stage IIIC2 endometrial cancer.
Bogani G; Cappuccio S; Casarin J; Narasimhulu DMM; Cilby WA; Glaser GE; Weaver AL; McGree ME; Keeney GL; Weroha J; Petersen IA; Mariani A
Int J Gynecol Cancer; 2020 Aug; 30(8):1169-1176. PubMed ID: 32646864
[TBL] [Abstract][Full Text] [Related]
14. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.
Hiura M; Nogawa T; Matsumoto T; Yokoyama T; Shiroyama Y; Wroblewski J
Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408
[TBL] [Abstract][Full Text] [Related]
15. Lymph Node Involvement Pattern and Survival Differences of FIGO IIIC and FIGO IIIA1 Ovarian Cancer Patients After Primary Complete Tumor Debulking Surgery: A 10-Year Retrospective Analysis of the Tumor Bank Ovarian Cancer Network.
Gasimli K; Braicu EI; Nassir M; Richter R; Babayeva A; Chekerov R; Darb-Esfahani S; Sehouli J; Muallem MZ
Ann Surg Oncol; 2016 Apr; 23(4):1279-86. PubMed ID: 26832880
[TBL] [Abstract][Full Text] [Related]
16. Endometrial cancer in premenopausal women 45 years and younger.
Gitsch G; Hanzal E; Jensen D; Hacker NF
Obstet Gynecol; 1995 Apr; 85(4):504-8. PubMed ID: 7898824
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic insight of simultaneously detected primary endometrial and ovarian carcinomas.
Rodolakis A; Thomakos N; Akrivos N; Sotiropoulou M; Ioannidis I; Haidopoulos D; Vlachos G; Antsaklis A
Arch Gynecol Obstet; 2012 Mar; 285(3):817-21. PubMed ID: 21842403
[TBL] [Abstract][Full Text] [Related]
18. Survival and prognostic factors in patients with synchronous ovarian and endometrial cancers and endometrial cancers metastatic to the ovaries.
Ayhan A; Guvenal T; Coskun F; Basaran M; Salman MC
Eur J Gynaecol Oncol; 2003; 24(2):171-4. PubMed ID: 12701972
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant therapy in stage III endometrial cancer: treatment outcomes and survival. a single-institution retrospective study.
Kuku S; Williams M; McCormack M
Int J Gynecol Cancer; 2013 Jul; 23(6):1056-64. PubMed ID: 23765205
[TBL] [Abstract][Full Text] [Related]
20. Lymphovascular Space Invasion Portends Poor Prognosis in Low-Risk Endometrial Cancer.
dos Reis R; Burzawa JK; Tsunoda AT; Hosaka M; Frumovitz M; Westin SN; Munsell MF; Ramirez PT
Int J Gynecol Cancer; 2015 Sep; 25(7):1292-9. PubMed ID: 26067863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
